Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy
Among HCM phenotypes, the prognosis of patients with end-stage HCM was markedly worse. The 2024 ACC/AHA and 2023 ESC guidelines well stratified SCD risk in patients with HCM; the 2024 ACC/AHA guidelines seemed to better stratify SCD risk between Classes 2a and 2b compared with the 2023 ESC guidelines.
Authors
- Jun Masuda (ORCID: https://orcid.org/0000-0003-3129-514X)
- Akihiro Hayashida (ORCID: https://orcid.org/0000-0002-9074-9407)
- Kaoru Dohi (ORCID: https://orcid.org/0000-0002-5078-6326)
- Satoshi Yuda
- Shouji Matsushima
- Takao Kato (ORCID: https://orcid.org/0000-0001-8213-7999)
- Hiroaki Kitaoka
- Yasushi Sakata (ORCID: https://orcid.org/0000-0002-5618-4721)
- Kunihiro Nishimura (ORCID: https://orcid.org/0000-0002-0639-0949)
- Kenji Andò (ORCID: https://orcid.org/0000-0003-0699-4248)
- Atsushi Okada (ORCID: https://orcid.org/0000-0002-0087-4168)
- Haruhiko Abe (ORCID: https://orcid.org/0000-0001-8712-5137)
- Yusuke Yoshikawa (ORCID: https://orcid.org/0000-0001-8082-2036)
- Katsuomi Iwakura (ORCID: https://orcid.org/0000-0001-6617-1521)
- Moriaki Inoko (ORCID: https://orcid.org/0000-0003-1388-4899)
- Yukichi Tokita (ORCID: https://orcid.org/0000-0001-9897-0918)
- Kazushige Kadota (ORCID: https://orcid.org/0000-0003-2845-9561)
- Takashi Omura
- Chisato Izumi (ORCID: https://orcid.org/0000-0002-3282-1327)
- Masashi Amano (ORCID: https://orcid.org/0000-0003-4095-1567)
- Takeshi Kitai (ORCID: https://orcid.org/0000-0003-2416-5865)
- Takahiro Ohara (ORCID: https://orcid.org/0000-0002-3350-3435)
- Tetsuya Kitamura
- Yutaka Furukawa
- Kenji Nakamura (ORCID: https://orcid.org/0009-0003-9884-9263)
- Toshihiro Tamura
- Takashi Tanigawa
- Yuji Abe
Institutions
- Kyushu University (JP)
- Mie University (JP)
- Kyoto University (JP)
- Tenri Hospital (JP)
- Kurashiki Central Hospital (JP)
- Osaka National Hospital (JP)
- Osaka City General Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Sakakibara Hospital (JP)
- Mie Chuo Medical Center (JP)
- Teine Keijinkai Hospital (JP)
- Sakurabashi Watanabe Hospital (JP)
- Sunagawa City Medical Center (JP)
- Ise Red Cross Hospital (JP)
- Kitano Hospital (JP)
- Kokura Memorial Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
- Kōchi University (JP)
- Nippon Medical School (JP)
- Tohoku Medical and Pharmaceutical University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- JACC Heart Failure
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1016/j.jchf.2024.12.006
- Citations
- 8
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- Japan Agency for Medical Research and Development